by Marisa Messick | Oct 30, 2024 | Blog
As we all know, the COVID-19 pandemic required pharmaceutical companies to put to the test how fast vaccines, treatments, and diagnostics could be developed, tested, and implemented on a large scale. With this wave of need in the biotech sector, investments in biotech...
by Marisa Messick | Oct 24, 2024 | Podcasts
New research on Adverse Childhood Experiences (ACEs) demonstrates an overwhelming negative correlation between the severity/frequency of childhood trauma and lifetime well-being outcomes. Ed Long overcame childhood trauma to pursue a Master’s of Public...
by Marisa Messick | Oct 10, 2024 | Podcasts
Tech exit to selling “commoditized” water bottles on Amazon? Mike Beckham must be crazy! After 9 years of rapid growth with his company Simple Modern, Mike has proved his doubters wrong by leaning into competition to eliminate market risk. Tune in to hear...
by Marisa Messick | Oct 10, 2024 | Blog
You are in one of these two camps — those who believe that clean energy is the future and those who think the future is uncertain. VCs were in the first camp in 2006. By 2011, they decamped, and funds for clean tech dried up [Fig 1]. As of 2008, over 8% of venture...
by Marisa Messick | Oct 1, 2024 | Newsletters
Why We Invested in Prelude, EXUM Instruments Highlight, Boddle Named as Finalist for $500,000 Yass Prize, and more. Cortado Ventures Oct 09, 2024 Share BLUF (Bottom Line Up Front) Read the latest Why We Invested blog featuring our investment in Prelude. Our 2024-2025...